Related Experiment Video

Updated: Feb 17, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.7K

TRPV1 is a physiological regulator of μ-opioid receptors

Paul C Scherer1, Nicholas W Zaccor1, Neil M Neumann2

  • 1The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Proceedings of the National Academy of Sciences of the United States of America
|December 6, 2017
PubMed

Insights

Transient receptor potential channel vanilloid 1 (TRPV1) modulates μ-opioid receptor (MOR1) signaling. TRPV1 blocks MOR1 phosphorylation, reducing side effects while preserving pain relief, offering a novel therapeutic strategy.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Opioids are effective analgesics but are associated with significant side effects and abuse potential.
  • Opioid-induced adverse effects, such as tolerance and respiratory depression, are mediated by the β-arrestin pathway.
  • The μ-opioid receptor (MOR1) is a key target for opioid drugs, and its signaling pathways are complex.

Purpose of the Study:

  • To investigate the role of the transient receptor potential channel subfamily vanilloid member 1 (TRPV1) as a modulator of MOR1.
  • To determine if TRPV1 can selectively inhibit MOR1 phosphorylation without affecting G protein signaling.
  • To explore the potential of targeting the TRPV1-MOR1 interaction for improved opioid therapy.

Main Methods:

  • Biochemical assays to assess the interaction between TRPV1 and MOR1.
  • Measurement of MOR1 phosphorylation levels in the presence and absence of TRPV1.
  • Analysis of G protein signaling and β-arrestin recruitment downstream of MOR1 activation.
  • Investigating the role of calcium influx and GRK5 translocation in the TRPV1-mediated effect.

Main Results:

  • TRPV1 was found to bind to MOR1.
  • TRPV1 effectively blocked opioid-induced phosphorylation of MOR1.
  • This blockade occurred without interfering with the G protein signaling pathway responsible for analgesia.
  • Calcium influx through TRPV1 led to GRK5 translocation, preventing MOR1 phosphorylation.

Conclusions:

  • TRPV1 acts as a negative modulator of MOR1 phosphorylation by inhibiting GRK5 activity.
  • TRPV1 selectively uncouples MOR1 from the β-arrestin pathway while preserving G protein signaling.
  • Targeting the TRPV1-MOR1 interaction represents a promising strategy to develop safer and more effective opioid analgesics.
Keywords:
G protein-coupled receptor kinase 5G protein-coupled receptorsopiatestransient receptor potential vanilloid 1μ-opioid receptor

More Related Videos

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

8.9K
A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice08:35

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice

Published on: March 17, 2015

15.7K

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.1K
Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
34.0K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.1K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.5K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.3K